News

Network and Learn: Research Park Lunch & Learn

Alameda, CA – September 13, 2024 – Emery Pharma, a leading contract research organization (CRO) specializing in preclinical drug development, is excited to announce an upcoming event where its founder…

Read More

Emery Pharma Expands Analytical Services to Support Biopharma Companies Affected by the BIOSECURE Act

September 12, 2024– In response to the recent passage of the BIOSECURE Act, which seeks to reduce U.S. dependence on foreign biotechnology firms, particularly in China, Emery Pharma is pleased…

Read More

Emery Pharma Recognized in Leading Cancer Research Article

September 9, 2024 – Emery Pharma is proud to announce that Emery Pharma and Dr. Prajita Pandey, have been recognized for their contribution in a recent Genetic Engineering & Biotechnology…

Read More

Emery Pharma and Marin Biologic Laboratories Announce Strategic Partnership to Advance Drug Development Capabilities

Alameda, CA, and Novato, CA – September 10, 2024 – Emery Pharma, a leader in bioanalytical chemistry, mass spectrometry, and CMC services, and Marin Biologic Laboratories, a premier provider of…

Read More

Emery Pharma to Exhibit at Pharmaceutical Bioscience Society (PBSS) Events in Foster City, California

Emery Pharma is excited to announce its attendance and exhibition at the following Pharmaceutical Bioscience Society events in Foster City, CA. These events will gather industry leaders and innovators, providing…

Read More

Important Notice: Beware of Fraudulent Job Offers

It has come to our attention that there are unauthorized scammers, who are impersonating and circulating fraudulent job offers on behalf of our company. These offers are not legitimate and…

Read More

Emery Pharma to Present at AAPS Summer Scientific Forum in Kansas City 2024

Alameda, CA – Emery Pharma is proud to announce its participation and presentation at the upcoming AAPS Summer Scientific Forum, to be held in Kansas City from July 22-25, 2024….

Read More

Emery Pharma and Telo Genomics Announce Collaboration

Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) (the “Company” or “Telo”) a biotech company developing the industry’s leading telomere technology platform with diagnostic and prognostic applications in oncology is pleased to announce that…

Read More

Emery Pharma Exhibiting at the 2024 AAPS National Biotechnology Conference in San Francisco, California

Alameda, CA – Emery Pharma is thrilled to announce its participation as an exhibitor at the 2024 AAPS National Biotechnology Conference, scheduled to be held on May 13-16, 2024, at the…

Read More

Emery Pharma Exhibiting at the 2024 Society of Toxicology Annual Meeting in Salt Lake City, Utah

Alameda, CA – Emery Pharma is excited to announce its participation as an exhibitor at the Society of Toxicology (SOT) Annual Meeting, scheduled to be held on March 10-13, 2024, at…

Read More